Alterations of genomic features and tumor immune microenvironment predict immunotherapy outcomes in advanced biliary tract cancer
Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e740
DOI: 10.1055/s-0044-1789922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von C. Huang und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
The response to immunotherapy is limited in a portion of patients with advanced biliary tract cancer (BTC). In this study, a novel predictive model is proposed in order to identify advanced BTC patients with active response to immunotherapy.
Methods
This study included 55 patients with advanced BTC, who received anti-PD-1 treatment. 520 gene panel sequencing was performed in 30 patients, while multiplex circulating cytokine testing was done in 50 patients. Entropy and mutation features were analyzed using the previously optimized pipeline. The repeated LASSO algorithm was used to identify the optimal features. The associations between sequence features and cell communication were explored by analyzing publicly available single-cell transcriptome data of BTC (GSE125449). Cox regression was used to develop an integrated model. Prediction performance was assessed by time-dependent C-index, Kaplan-Meier, and receiver operating characteristic curve determination.
Results
TP53, NRAS, FBXW7 and APC were identified as prognosis related genes. The average C-index of sequence entropy and mutation for overall survival were 0.819 and 0.817, respectively. They were significantly higher than 0.392 and 0.638 in tumor mutation burden and mutation score. Single-cell transcriptome data inferred that TP53, KRAS, and NRAS are enriched in plasmacytoid dendritic cells (pDCs), and that the communication between pDCs and macrophages is mediated through the CXCL signaling pathway. An EM-CXCL10 integrated model shows powerful predictive performance, including on survival status (AUC: 0.863, 95% CI: 0.643-0.972) and objective response rate (AUC: 0.990, 95% CI: 0.822-1.000), in patients receiving immunotherapy.
Conclusion
Through a multi-dimensional strategy, this study presents a promising predictive model for selecting BTC patients prone to immunotherapy. A further clinical study with a large patients cohort is required to validate its predictive performance. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Huang, C., Qiu, Z., Huang, H., Xiao, X., Du, F., Ji, J., Xu, X., Ebert, M., Jiang, X., Dooley, S., Weng, H., Wang, Y., & Gao, C. (2024). Alterations of genomic features and tumor immune microenvironment predict immunotherapy outcomes in advanced biliary tract cancer. Zeitschrift für Gastroenterologie, 62(09), e740. https://doi.org/10.1055/s-0044-1789922
Vancouver
Huang C, Qiu Z, Huang H, Xiao X, Du F, Ji J, et al. Alterations of genomic features and tumor immune microenvironment predict immunotherapy outcomes in advanced biliary tract cancer. Zeitschrift für Gastroenterologie. 2024;62(09):e740. doi:10.1055/s-0044-1789922
BibTeX
@article{Huang2024,
author = {Huang, C. and Qiu, Z. and Huang, H. and Xiao, X. and Du, F. and Ji, J. and Xu, X. and Ebert, M. and Jiang, X. and Dooley, S. and Weng, H. and Wang, Y. and Gao, C.},
title = {Alterations of genomic features and tumor immune microenvironment predict immunotherapy outcomes in advanced biliary tract cancer},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {09},
pages = {e740},
doi = {10.1055/s-0044-1789922}
}
EUVIMED